| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net decrease in cash and cash equivalents from continuing operations | - | -295 |
| Cash used in operating activities | 0 | 0 |
| Cash used in investing activities | 0 | 0 |
| Cash provided by financing activities | 0 | 0 |
| Net cash used in discontinued operations | 0 | 0 |
| Loss from discontinued operations | 0 | - |
| Benefit for current and deferred income taxes | 0 | 1 |
| Net losses on disposal/write-offs of property, plant and equipment and intangible assets | 0 | 0 |
| Net periodic cost of defined benefit obligation | 0 | 0 |
| (increase) in due from related parties | 0 | 0 |
| Operating lease asset and liabilities | 0 | 0 |
| Fair value change of warrant liability | 0 | 0 |
| Depreciation of property and equipment | 563 | 391 |
| Amortization of intangible assets | 21 | 14 |
| Net loss from discontinued operations | - | 0 |
| Credit loss allowance | -485 | -464 |
| Net loss from continuing operations | - | -7,071 |
| Provision for litigation expenses | 1,034 | 1,034 |
| Stock-based compensation expense | 677 | 550 |
| Issuance of pre-funded warrants | 721 | - |
| Provision for inventories | -45 | -34 |
| Gain on settlement of payable | 11,669 | - |
| Accretion of discount on debt | 303 | - |
| Decrease/(increase) in accounts receivable | -896 | -470 |
| Decrease/(increase) in contract assets | -6 | -6 |
| Decrease/(increase) in inventories | -53 | -42 |
| Increase in prepaid expenses and other current assets | -147 | -6 |
| Decrease in other long-term liabilities | - | 0 |
| Decrease in other non-current assets | -83 | 0 |
| (decrease)/increase in trade payables | 1,243 | 524 |
| (decrease)/increase in due to related parties | -82 | -82 |
| (decrease)/increase in deferred income from grants | 1,194 | 1,310 |
| Increase in loss contingency liability | 231 | 172 |
| (decrease)/increase in contract liabilities | 927 | 506 |
| (decrease)/increase in other current liabilities | 599 | 374 |
| Net loss for the nine months ended | 1,554 | -7,071 |
| Net cash provided by / (used in) operating activities from continuing operations | -895 | -1,159 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Purchases of property and equipment | 6 | 5 |
| Purchases of intangible assets | 24 | 24 |
| Net cash provided by / (used in) investing activities from continuing operations | -30 | -29 |
| Issuance of common stock | 1,249 | 0 |
| Repayments of debt | 2,032 | 1,442 |
| Proceeds from borrowings | 2,901 | 2,335 |
| Net cash provided by financing activities from continuing operations | 2,118 | 893 |
| Net decrease in cash and cash equivalents from continuing operations | 1,193 | - |
| Effect of exchange rate changes on cash and cash equivalents | -1,106 | 11 |
| Net decrease in cash and cash equivalents | 87 | -306 |
| Cash and cash equivalents at beginning of period | 381 | - |
| Cash and cash equivalents at end of period | 468 | - |
ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)
ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)